<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0023">
 <label>23</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Leanderson</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liberg</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ivars</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>S100a9 as a pharmacological target molecule in inflammation and cancer</article-title>. 
  <source>Endocr Metab Immune Disord Drug Targets</source>. 
  <year>2015</year>;
  <volume>15</volume>(
  <issue>2</issue>):
  <fpage>97</fpage>â€“
  <lpage>104</lpage>. doi:
  <pub-id pub-id-type="doi">10.2174/1871530315666150316123854</pub-id>
  <pub-id pub-id-type="pmid">25772177</pub-id>
 </mixed-citation>
</ref>
